NCI Standard Funding Opportunity Announcements
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
Ongoing |
All Ranks |
Federal |
See BAA |
Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
The purpose of this BAA is to solicit research proposals in the
engineering, physical, life, and information sciences for
submission to the Army Research Office (ARO) for consideration
for possible funding.
Due Dates: |
Open until March 31, 2017
Proposers are to submit white papers prior to submission of a
complete proposal. Based on assessment of white papers, feedback will be
provided to encourage or discourage submission of full proposals. |
Amount & Project Period: |
No specific dollars have been reserved 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Links: |
ARO CORE
BAA-W911NF-12-R-0012-Mod 03
|
|
|
Ongoing |
All Ranks |
Non-federal |
Macroglobulinemia |
International Waldenstrom's Macroglobulinemia Foundation
Research Grants
To further scientific knowledge of the cause, diagnosis,
treatment, or cure for the disease Waldenstrom's
Macroglobulinemia, a type of non-Hodgkin's Lymphoma also called
lymphoplasmacytic lymphoma.
Due Dates: |
Ongoing |
Amount & Project Period: |
$50,000 to $100,000 - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines
|
|
New FOA number |
October 1 through December 01 |
See below |
Federal |
Career Development |
Research
Supplements to
Promote Re-Entry
into Biomedical
and Behavioral
Research Careers
Supports
individuals with
high potential
to re-enter a
research career
after an
interruption
Funding is
provided to
existing NIH
research grants
for the purpose
of supporting
full-time or
part-time
research by
these
individuals to
update their
existing
research skills
and knowledge.
Due Dates: |
For NCI: Applications accepted
from Oct 01 to Dec 01. Proposals must be delivered to OSR a minimum of
2 days prior to submission. |
Amount & Project Period: |
Requested salary and fringe benefits for a
re-entry candidate must be in accordance w/salary structure of the
grantee institution, consistent w/level of effort. An additional $10,000
may be requested for other relevant costs. |
Eligibility: |
Research proposed for supplement must be
accomplished w/in the competitive segment of the active award. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-321 |
|
New FOA Number |
October 1 through December 01
|
See Below |
Federal |
Career Development |
Research
Supplements to
Promote
Diversity in
Health-Related
Research
Administrative
supplements to
improve
diversity of
research
workforce by
recruiting and
supporting
students,
postdocs,
and eligible
investigators
from groups that
have been shown
to be
underrepresented
in
health-related
research.
Due Dates: |
For NCI: Applications accepted
from Oct 01 to Dec 01. Proposals must be delivered to OSR a minimum of 2
days prior to submission. |
Amount & Project Period: |
Limited to no more than the amount of current
parent award, and must reflect actual needs of the proposed project
For NCI: Annual Salary Cap for Investigators Developing
Independent Research Careers: $75,000 plus fringe benefits |
Eligibility: |
Parent award must be active and research
proposed must be accomplished within the competitive segment. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-322 |
|
NEW |
October 07 (LOI) |
Postdocs |
Non-federal |
Career Development |
American
Association for
Cancer Research
Basic Cancer
Research
Fellowships
Research
proposed for
funding may be
in any area of
basic cancer
research.
Due Dates: |
Oct 07 (letter of Intent)
Invited Applications: Jan 17 (OSR) │ Jan 19 (Sponsor)
|
Amount & Project Period: |
$50,000 - 1 year |
Eligibility: |
Must have completed most recent doctoral degree
or medical residency w/in last 3 years
No citizenship requirements
AACR membership is required (Must submit application for AACR Associate
Membership by October 7, 2015.) |
Contact: |
Linda Nolan (x6071)
|
Links: |
Basic Cancer Research Fellowships
Open Funding Opportunities
|
|
NEW |
October 08 (LOI) |
Jr faculty |
Non-federal |
Pancreatic |
Pancreatic
Cancer Action
Network - AACR
Career
Development
Award
Supports a newly independent investigator develop or strengthen a research
program with
direct
applicability
and relevance to
pancreatic
cancer.
Due Dates: |
October 08 (Letter of Intent)
Invited Applications: Jan. 12 (OSR) Ι Jan 14 (Sponsor)
|
Amount & Project Period: |
$200,000 - 2 years |
Eligibility: |
Full-time faculty
position w/title of asst. professor, instructor, research
assistant professor, or equivalent
Completed most recent doctoral degree
w/in past 11 years (i.e., cannot have been conferred before July 2,
2005)
Applicants with a medical degree must
have completed most recent doctoral degree or medical residency -
whichever date is later - w/in the past 11 years (time spent in medical
specialty or subspecialty training will be counted against the 11 year
window)
Have independent laboratory space as
confirmed by institution There are no citizenship requirements. AACR
Membership required |
Contact: |
Linda
Nolan (x6071) |
Links: |
Program Guidelines and Letter of Intent Instructions
Apply for a Pancreatic Cancer Research Grant
|
|
Division of Program Coordination, Planning and Strategic
Initiatives,
Office of Strategic Coordination (Common
Fund)
|
October 09 |
All Faculty |
Federal |
Career Development |
NIH Pioneer
Award Program
This award
complements
NIH's
investigator-initiated
grant programs
by supporting
individual
scientists of
exceptional
creativity who
propose
pioneering and
possibly
transforming
approaches to
addressing major
biomedical or
behavioral
challenges
having potential
to produce an
unusually high
impact on a
broad area of
biomedical or
behavioral
research.
Proposed
research must
reflect
substantially
different
scientific
directions from
those already
being pursued in
the
investigator's
research program
or elsewhere.
Due Dates: |
Oct 07 (OSR) - Oct 09 (Sponsor)
|
Amount & Project Period: |
$700,000/yr (Direct Costs) - 5 years
|
Eligibility: |
All Faculty - Single PD/PI applications only
|
Contact: |
Linda
Nolan (X6071) |
RFA Link: |
RFA-RM-13-006 |
|
|
October 12 (LOI) |
All Faculty |
Non-federal |
Melanoma |
Melanoma
Research
Alliance (MRA)
Team Science
Awards
Special Emphasis Areas:
1) Define logical and
optimal
combination
therapies,
therapeutic
sequences, or
treatment
regimens;
2)
Biomarkers of
risk of
recurrence or
death in early
stage disease to
speed
development of
adjuvant
therapies;
3)
Research leading
to improvements
in
difficult-to-treat
disease or
treatment
failures;
4) Improving
understanding of
biological basis
for melanoma
formation.
Due Dates: |
Oct 12 (Letter of Intent)
Invited Applications: Jan 06 (OSR) Ι Jan 08
(Sponsor) |
Amount & Project Period: |
$900,000 - 3 years |
Eligibility: |
Assistant Professor (or equivalent) or above.
Multidisciplinary teams of two or more established Principal
Investigators and a Young Investigator with complementary expertise.
|
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals
|
|
|
October 12 (LOI) |
All Ranks |
Non-federal |
Pediatric Cancers |
A
Collaborative
Pediatric Cancer
Research Awards
Program
2016 Grant
Funding
Opportunity in
Pediatric
Oncology
A Collaborative Pediatric Cancer Research Awards Program is a national
nonprofit
organization
dedicated to
eliminating
childhood cancer
through
innovative
research. Areas
of Interest:
(1) Innovative
approaches to
pediatric cancer
research, which
could
potentially
become advanced
studies or
clinical trials;
(2) Projects
w/translational
components
(likely to lead
to clinical
trial in near
future); (3)
Survivorship
studies;
(4)
Personalized,
alternative, or
integrative
research
proposals; (5)
Grants for
junior faculty
development in
pediatric cancer
research at
instructor or
assistant
professor level;
(6) Pediatric
Cancer Research
Fellowships for
2nd, 3rd or 4th
year postdocs.
|
NCI is a participating Institute
|
October 13 (LOI) |
All Ranks |
Federal |
Tobacco Research |
Chemistry,
Toxicology, and
Addiction
Research on
Waterpipe
Tobacco
Research that will inform the development and evaluation of possible
regulatory
action on
waterpipe (or
hookah) tobacco
products.
Due Dates: |
Oct 13 (Letter of
Intent) Although letters of intent are typically requested 1 month prior to the
submission due date, letters of intent for this FOA are requested on Oct 13
Application: Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Not to exceed $300,000/yr (Direct Costs) - 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-OD-15-005 |
|
Bi-annual deadline |
October 15 |
See Below |
Non-Federal |
See Below |
American Cancer
Society
Due Dates: |
Oct 13 (OSR) - Oct 15 (Sponsor)
NOTE: Paper copies are due one day after submission of the electronic
copy. |
Contact: |
Linda
Nolan (X6071) |
|
|
Research and
Training Grants
- Career
Development
Amount & Project Period: |
Research
Scholar Grants: $165,000/yr (Direct Costs) - 4 years
Postdoctoral Fellowships:
Progressive stipends of $48,000, $50,000, and $52,000, plus a $4,000/yr
fellowship allowance Mentored Research
Scholar Grants: $135,000/yr - 5 years
|
Eligibility: |
See specifics in Program Announcement
|
PA Links: |
Independent
Investigators:
Research
Scholar Grants
Mentored Research Grants:
Postdoctoral Fellowships &
Mentored Research Scholar Grant
Submission Portal:
proposalCENTRAL |
|
Current RFA |
Pilot
and Exploratory
Projects in
Palliative Care
of Cancer
Patients and
Their Families
Funding for investigators performing pilot and exploratory research
studies whose
purpose is to
test
interventions,
develop research
methodologies,
and explore
novel areas of
research in
palliative care
of cancer
patients and
their families.
A condition of
funding is a
clearly defined
plan as to how
the investigator
will use the
results of the
project to
develop larger,
extramurally
funded research
projects.
|
Current RFA |
The Role
of Health Policy
and Health
Insurance in
Improving Access
to and
Performance of
Cancer
Prevention,
Early Detection,
and Treatment
Services
Research focus
on changes in
national, state,
and/or local
policy and
response to
these changes by
healthcare
systems,
insurers,
payers,
communities,
practices, and
patients.
|
NCI is a participating institute
|
October 15 |
See Below |
Federal |
Supplemental Funding |
Administrative
Supplements for
Research on
Dietary
Supplements
To support
research in
which the
supplemental
funding would
investigate the
role of dietary
supplements
and/or their
ingredients in
health
maintenance and
disease
prevention.
Due Dates: |
Oct 13 (OSR) - Oct 15 (Sponsor) |
Amount & Project Period: |
$100,000
(Total Costs) - Limited to 1 year |
Eligibility: |
Active awards with at least 18 months remaining
at time of submission will be considered. Awards in no-cost extension
periods are not eligible. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-258 |
|
Semi-annual Due Date |
October 15 |
Jr faculty |
Non-federal |
Pilot Projects |
American Cancer
Society
Institutional
Research Grant
(ACS-IRG)
ACS-IRG Pilot
Project Funding
Opportunities
Pilot funding
opportunities to
support junior
faculty in
initiating
cancer-related
research
projects that
assist them in
competing
successfully for
national
research grants.
Due Date: |
October 15 (4:00pm) to
Maureen Ahearn
|
Amount & Project Period: |
$30,000 - 12 months |
Eligibility: |
Full-time faculty members at Assistant
Member/Assistant Professor level or equiv. are eligible
Must be w/in first 6 years of initial faculty appointment
May not have any active peer-reviewed funding at time of submission or
award
Research Scientists are eligible to apply. Must be independent and w/in
2 years of a tenure-track appointment |
Contact: |
Maureen Ahearn (x8824) |
Links: |
Guidelines Ι
Application |
|
Division of Program Coordination, Planning and Strategic
Initiatives, Office of Strategic Coordination (Common
Fund)
|
October 16 |
Jr Faculty |
Federal |
Career
Development |
NIH
Director's New
Innovator Award
Program
This award
initiative
supports early
stage
investigators of
exceptional
creativity
proposing bold
and highly
innovative new
research
approaches that
have the
potential to
produce a major
impact on broad,
important
problems in
biomedical and
behavioral
research.
Due Dates: |
Oct 14 (OSR) - Oct 16 (Sponsor)
|
Amount & Project Period: |
$300,000/yr (Direct Costs) - 5 years
|
Eligibility: |
Applicants must meet the definition of an Early
Stage Investigator (ESI) Must hold an independent research position as
of Sept 01. Required to commit at least 25% research effort each
year to activities supported by this award |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-RM-13-007 |
|
|
October 17 (LOI) |
All Clinical Faculty |
Federal |
Imaging & Precision
Medicine |
Oncology
Co-Clinical
Imaging Research
Resources to
Encourage
Consensus on
Quantitative
Imaging Methods
and Precision
Medicine
Scientific Goals:
(a) Perform
appropriate
optimization of
pre-clinical
quantitative
imaging methods,
(b) Implement
optimized
methods in
co-clinical
trial,
(c) Populate a
web-accessible
research
resource with
all data,
methods,
workflow
documentation,
and results
collected from
the co-clinical
investigations.
Due Dates: |
Oct 17 (Letter of Intent)
Nov 15 (OSR) - Nov 17 (Sponsor) |
Amount & Project Period: |
$500,000/yr (Direct Costs) - 5 years |
Eligibility: |
All Clinical Faculty |
Contact: |
Linda
Nolan (X6071) |
FOA Link: |
PAR-15-266 |
|
|
October 18 |
See Below |
Federal |
Genomics |
Supplements
to Support
Evaluation of
the NCI Cancer
Genomics Cloud
Pilots
To support projects that will incorporate the use of one or more of the
NCI Cancer
Genomics Cloud
Pilots into
ongoing research
activities.
Due Dates: |
Oct 16 (OSR) - Oct
18 (Sponsor) |
Amount & Project Period: |
$40,000 (Direct Costs) Must be w/in currently
approved project period of existing parent award and work must be
completed no later than September 30, 2016. |
Eligibility: |
Announcement is for supplements to existing
projects (R01, R21, U01, U24).
Parent award must be active and research proposed in supplement must be
accomplished w/in competitive segment. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-305 |
|
NEW |
October 20 (LOI) |
All Faculty |
Federal |
Cancer Systems Biology
|
Research
Centers for
Cancer Systems
Biology
Consortium
To fund Research
Centers that
utilize systems
biology
approaches to
build predictive
models of cancer
initiation,
progression and
metastasis.
Due Dates: |
Oct 20 (Letter of Intent)
Applications due: Nov 18 (OSR) Nov 20 (Sponsor) |
Amount & Project Period: |
1.5M/yr (Direct Costs) - 5 years |
Eligibility: |
All Faculty
Contact PD/PI for multiple PD/PI submissions must be a scientist
w/formal training and/or expertise in cancer systems biology, with
contributions demonstrating substantial impact on the field. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-014 |
|
NEW |
October 20 (LOI) |
All Faculty |
Federal |
Cancer Systems Biology |
Coordinating
Center for the
Cancer Systems
Biology
Consortium and
the Physical
Sciences-Oncology
Network
Coordinating
Center is
expected to
focus on three
activities: (1)
development of
an integrative
Resource
Coordinating
Hub, a curated
resource of CSBC
and PS-ON
research output,
(2)
Collaboration
and Pilot
Project Hub, a
restricted fund
for promotion of
CSBC-led
trans-consortium
research
projects, and
(3)Outreach Hub
for promoting
the research
goals of the
CSBC and PS-ON.
Due Dates: |
Oct 20 (Letter of Intent)
Applications due: Nov 18 (OSR) Nov 20 (Sponsor) |
Amount & Project Period: |
$750,000/yr (Direct Costs) - 5 years |
Eligibility: |
All faculty - contact PD/PI for applications
with multiple PD(s)/PI(s)) must be a scientist with strong expertise in
cancer systems biology, computational biology, or mathematical modeling
techniques. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-015 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Technologies |
Advanced
Development of
Informatics
Technologies for
Cancer Research
and Management
Advanced development and enhancement of emerging informatics technologies
to improve the
acquisition,
management,
analysis, and
dissemination of
data and
knowledge across
the cancer
research
continuum,
including cancer
biology, cancer
treatment and
diagnosis,
cancer
prevention,
cancer control
and
epidemiology,
and/or cancer
health
disparities.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Not to exceed $600,000/yr (Direct Costs) - 5
years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-331 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Technologies |
Early-Stage
Development of
Informatics
Technologies for
Cancer Research
and Management
For development of enabling informatics technologies to improve the
acquisition,
management,
analysis, and
dissemination of
data and
knowledge across
the cancer
research
continuum.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
$300,000/yr (Direct Costs) - 3 years
|
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-332 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Resources |
Sustained
Support for
Informatics
Resources for
Cancer Research
and Management
For continued development and sustainment of high-value informatics
research
resources to
serve current
and emerging
needs across the
cancer research
continuum.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Budgets are not
limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-333 |
|
|
October 20 (LOI) |
All Ranks |
Federal |
Innovative Informatics |
Development
of Innovative
Informatics
Methods and
Algorithms for
Cancer Research
and Management
Encourages
applications
focused on the
development of
novel
computational,
mathematical,
and statistical
algorithms and
methods that can
considerably
improve
acquisition,
management,
analysis, and
dissemination of
relevant data
and/or
knowledge.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-334 |
|
NEW |
October 20 |
Postdocs |
Non-federal |
Career Development |
Debbie's Dream Foundation-AACR
Gastric Cancer Research Fellowship
Research proposed for funding may be basic, translational,
clinical, or epidemiological in nature and must have direct
applicability and relevance to gastric cancer, specifically
non-Helicobactor pylori associated gastric cancer.
|
NEW |
October 20 |
Jr Faculty |
Non-federal |
Career Development |
Debbie's Dream Foundation-AACR
Career Development Award for Gastric Cancer Research
Research proposed for funding may be basic, translational, clinical, or
epidemiological in nature and must have direct applicability and
relevance to gastric cancer, specifically non-Helicobactor
pylori associated gastric cancer
|
Re-issue of PAR-14-267
|
October 23 (LOI) |
Established Investigators |
Federal |
Research Support |
NCI
Outstanding
Investigator
Award
Provides long-term support to accomplished investigators with outstanding
records of
cancer research
productivity who
propose to
conduct
exceptional
research.
Due Dates: |
October 23 (Letter of Intent)
Applications Due: Nov
21 (OSR) Ι Nov 23 (Sponsor) |
Amount & Project Period: |
$600,000/yr (Direct Costs) - 7 years |
Eligibility: |
Only single PD/PI applications are allowed
PD/PI must have been PI on eligible NCI grants continuously since
9/2005.
At least 50% (6 calendar months) of total effort to the direct
conduct of biomedical research (excluding patient and clinical
responsibilities) required. |
Contact: |
Linda
Nolan (x6071) |
PAR Link: |
PAR-15-342 |
|
|
October 23 (LOI) |
All Ranks |
Federal |
Detection/Prevention/Risks |
Translational
Research on
Adducts in
Cancer Risk
Identification
and Prevention
Encourages clinically-relevant translational/epidemiological research
projects focused
on the use of
adducts to
cellular
macromolecules,
as indicators of
exposures to
cancer risk
factors in human
populations and
subgroups.
Priority is on
projects that
will focus on
adductomic
approaches,
i.e., address
some aspects of
the totality of
adducts. Main
emphasis is on
advancing the
area of cancer
detection,
cancer
prevention, and
assessing cancer
risks in human
populations and
subgroups.
Due Dates: |
Letter of Intent due 30 days prior to
application due date
Applications: Nov 21 (OSR) - Nov 23
(Sponsor) |
Amount & Project Period: |
U01 & R01: Budgets not limited - 5 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
U01:
PAR-15-307
R01:
PAR-15-308
R21:
PAR-15-309 |
|
|
October 25 (LOI) |
All Faculty |
Federal |
Pancreatic |
The Pancreatic Cancer Detection Consortium
To establish the
Pancreatic
Cancer Detection
Consortium
(PCDC) to
conduct research
to improve
detection of
early stage
pancreatic
ductal
adenocarcinoma
(PDAC) and
characterization
of its precursor
lesions.
Intended to
support research
for development
and testing of
new molecular
and imaging
biomarkers for
identifying
patients at high
risk for PDAC
who could be
candidates for
early
intervention.
Due Dates: |
Oct 25 (Letter of Intent)
Nov 23 (OSR) - Nov 25 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda Nolan (x6071) |
FOA Link: |
PAR-15-289 |
|
NEW |
October 26 |
All Faculty |
Non-federal |
Solid Tumors |
National
Comprehensive
Cancer Network®
(NCCN®)
NCCN
Mirvetuximab
Soravtansine-Preclinical
Research Grant
Opportunity
To support NCCN
investigator
initiated
pre-clinical
studies of
mirvetuximab
soravtansine
(previously
known as
IMGN853) in
solid tumors of
special
interest.
Overall aim of
this RFP is to
develop
innovative
studies of
mirvetuximab
soravtansine in
lung, breast,
mesothelioma,
endometrial,
ovarian and
gastric cancers.
Due Dates: |
October 24 (OSR) Ι October 26 (Sponsor)
|
Amount & Project Period: |
$100,000, (Total, incl. 25% indirect costs) -
18 months |
Eligibility: |
All Faculty |
RFP Link: |
RFP accessed by signing in as a member at
NCCN.org/clinical_trials/investigators
|
|
NEW |
October 26 (LOI) |
Established Faculty |
Non-federal |
Sarcoma |
Alliance for
Cancer Gene
Therapy
2015
Investigator's
Award in
Clinical
Translation of
Cell and Gene
Therapy for
Sarcoma
ACGT is
accepting grant
applications to
produce and
release-testing
of clinical
trial agents
under cGMP,
conduct
necessary
pre-clinical
pharmacological
and
toxicological
studies in
appropriate
animal models,
and/or
conducting
clinical
translational
trials in
patients in
support of an
Investigative
New Drug (IND)
application to
the FDA.
Due Dates: |
Oct 26 (Letter of Intent)
Invited Applications: Jan 16 (OSR) Jan 18 (Sponsor)
|
Amount & Project Period: |
$500,000 (TOTAL) - 3 years |
Eligibility: |
Must be a tenure-track or tenured faculty
No citizenship restrictions |
Contact: |
Linda
Nolan (x6071) |
Link: |
proposalCENTRAL
|
|
NEW |
October 27 |
Jr Faculty |
Non-federal |
Career Development |
Pancreatic
Cancer Action
Network – AACR
Pathway to
Leadership Grant
Supports outstanding early career investigators beginning in their
postdoctoral
research
positions and
continuing
through their
successful
transition to
independence
Mentored Phase
and Independent
Phase included
in award
(similar to NIH
K99-R00).
|
NEW |
October 27 |
Jr Faculty |
Non-federal |
Career Development |
AACR-Aflac,
Inc.
Career
Development
Award for
Pediatric
Cancer Research
To encourage and
support junior
faculty to
conduct
pediatric cancer
research and
establish
successful
career paths in
this field.
Research may
be basic,
translational,
clinical, or
epidemiological
with direct
applicability
and relevance to
pediatric
cancer.
Due Dates: |
Oct 23 (OSR) Ι Oct 27 (12:00pm (EST))
(Sponsor) |
Amount & Project Period: |
$100,000 - 2 years |
Eligibility: |
Hold a full-time faculty position w/title of
instructor, research asst. professor, asst. professor, or equiv.
full-time faculty position Completed most recent medical residency or
doctoral degree w/in last 11 years
Have independent laboratory space
No
citizenship requirements
AACR membership is required |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
CDA for Pediatric Cancer Research
Open Funding Opportunities
|
|
|
October 28 |
All Ranks |
Federal |
Physics/Cancer
Biology |
National
Science
Foundation (NSF)
Directorate for
Mathematical &
Physical
Sciences
Division of
Physics
Investigator-Initiated
Research
Projects (PHY)
Physics of
Living Systems
Focus should be
on understanding
basic physical
principles that
underlie
biological
function.
From
Dear Colleague
Letter Below:
inter-
and
multi-disciplinary
research
at the
intersection of
physical and
life sciences
with a focus on
advancing the
fundamental
understanding of
cancer biology
to underpin
translational
research that
promotes the
prevention,
detection, and
treatment of
cancer diseases.
|
NEW |
October 30 |
See Below |
MOFFITT |
Cutaneous |
Moffitt
Skin Cancer
SPORE
Specialized
Program of
Research
Excellence
Career
Enhancement
Program (CEP) &
Developmental
Research
Program(DRP)
The
goal of the CEP
is to support
new Moffitt
investigators
in the
development of
an independent
research career
in translational
science focused
on cutaneous
malignancies.
The DRP
promotes
exploration of
innovative ideas
in translational
cutaneous
malignancy
research through
the funding of
pilot projects
proposed by
Moffitt
investigators.
Due Date: |
Oct 30th submitted via e-mail to
joyce.lampasona@moffitt.org
by 5:00 p.m. (as a single file) |
Amount & Project Period: |
DRP: $50,000 to $100,000 Ι CEP: $50,000
to $75,000 - 1 year |
Eligibility: |
DRP: Assistant,
Associate or Full member level (or equivalent)
CEP:
New Moffitt Members at the rank of Asst. Member or equivalent; or
Established Moffitt investigators at the rank of Assoc. Member (Assoc.
Professor) or higher new to the field for careers in translational
research of cutaneous malignancies. |
Contact: |
Joyce Lampasona (x2007) |
Links: |
Skin Cancer Spore CEP-DRP Application
Skin Cancer Spore CEP-DRP Guidelines |
|
NCI is a participating Institute
NEW
|
October 30 (LOI) |
All Ranks |
Federal |
Tobacco Use |
Abuse
Liability
Associated with
Reduced Nicotine
Content Tobacco
To generate data
to inform the
FDA on ways to
reduce the
addictiveness
and resulting
public health
toll from
tobacco product
use
Due Dates: |
October 30 (Letter of Intent)
Applications Due: Dec 09 (OSR) Ι Dec 11 (Sponsor) |
Amount & Project Period: |
Not to exceed $500,000/yr (Direct Costs) - 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071 |
RFA Link: |
RFA-OD-15-006 |
|
|
October 30 (LOI) |
All Ranks |
Federal |
Palliative Care |
Exploratory
Multi-site
Palliative Care
Research in
Diverse
Populations
Utilizing the
Palliative Care
Research
Cooperative
(PCRC) Group
For research that enhances the knowledge-base of palliative care science
across diverse
populations
receiving
end-of-life and
palliative care
(EOLPC) through
multi-site
clinical
research that
utilizes the
infrastructure
and resources of
the Palliative
Care Research
Cooperative
(PCRC) Group.
Due Dates: |
Oct 30 (Letter of Intent)
Nov 28 (OSR) - Nov 30 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-337 |
|
|
November 01 |
See Below |
Non-federal |
Desmoid Tumors |
Desmoid Tumor
Foundation
Due Dates: |
Oct 30 (OSR) - Nov 01
(Sponsor) |
Contact: |
Linda
Nolan (x6071) |
|
|
General
Research Grants
Funds research
using
cutting-edge
science and
creative
clinical
applications, in
addition to
novel approaches
addressing
potential leads
based on prior
research.
Researchers must
be willing to
collaborate with
other scientists
and institutions
with similar
interests.
Amount & Project Period: |
$65,000/year - a minimum of 1 year
|
Eligibility: |
All Ranks |
Links: |
2015 RFP Ι
Research Grants |
|
|
New
Investigator
Research Grants
Funds early stage research to explore new approaches to advance current
scientific
knowledge about
desmoid tumors
This RFP seeks
applications
from young
investigators,
new to desmoid
tumor research
and in need of
seed funding to
gather
preliminary data
that will enable
applications for
funding to
support more
fully developed
lines of
research.
Amount & Project Period: |
$30,000/year - a minimum of 1 year
|
Eligibility: |
Individuals with an academic rank of
Instructor, Assistant Professor or Associate Professor who have not
previously received funding for independent research directed at desmoid
tumors are encouraged to apply |
Link: |
New
Investigator RFP Ι
Research Grants |
|
|
November 01 (LOI) |
All Faculty |
Non-federal |
Immunotherapies |
Cancer
Research
Institute
Clinic and
Laboratory
Integration
Program
Provides funding
to explore
clinically
relevant
questions aimed
at improving the
effectiveness of
cancer
immunotherapies.
Supports basic,
pre-clinical,
and
translational
research, which
will provide
information that
can be directly
applied to
optimizing
cancer
immunotherapy in
the clinic.
Due Dates: |
Nov 01 (Letter of Intent)
Invited Applications: Jan 30 (OSR) - Feb 01 (Sponsor) |
Amount & Project Period: |
$100,000/year - 2 years |
Eligibility: |
Must hold faculty appointment as a tenure-track
assistant professor or higher at time of award activation.
CRI has no citizenship restrictions, |
Contact: |
Linda
Nolan (x6071) |
Link: |
CLIP Application Guidelines |
|
NEW |
November 02 |
See Below |
Non-federal |
Blood |
American
Society of
Hematology
ASH Bridge
Grant Program
For ASH members who applied for an NIH R01 grant or equivalent in Basic,
Translational,
Patient-oriented,
or
Outcomes-based
research
projects, but
were denied
funding due to
budget cutbacks
Due Dates: |
October 31 (OSR)Ι November 02 (Sponsor)
|
Amount & Project Period: |
$100,000 (TOTAL) - 1 year
Requires $50,000
in matching funds from institution. |
Eligibility: |
Must hold a faculty position and must have
submitted a hematology-related R01 or equivalent in the past 18 months
that was scored but not funded (18 mo. timeline linked specifically to
date submission was reviewed by the NIH study section).
Be an ASH member or have a pending application for membership at the
time of application |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines |
|
NEW |
November 03 |
All Ranks |
Non-federal |
Esophagus and Stomach |
6th Annual
DeGregorio
Foundation
Award for
Cancers of the
Esophagus and
Stomach
Seed funding for
research in
upper GI
malignancies to
promote and
facilitate
collaborative
research on the
pathogenesis,
early diagnosis,
and treatment of
upper
gastrointestinal
malignancies.
|
NEW |
November 03 (LOI) |
Jr faculty |
Non-federal |
Palliative Care |
National Palliative Care Research Center
Pilot and Exploratory Project Support Grant
Focus is on improving care for seriously ill patients and their families
must conduct research projects whose purpose is to test
interventions, develop research methodologies
Due Dates: |
Nov 03 (Letter of Intent)
Invited Applications: January 13 (OSR) January 15 (Sponsor)
|
Amount & Project Period: |
$70,000 (Direct Costs) - 2 years
|
Eligibility: |
Must have full-time faculty position or equiv
by award start Must be citizens/permanent residents of the United States
Should have minimum of 5 years postdoctoral experience. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
NPCRC Funding Opportunities
|
|
NEW |
National Palliative Care Research Center
Junior Faculty Career Development Award
Areas of Interest: 1. Relationship of pain /other distressing
symptoms to quality and quantity of life, independence,
function, and disability; developing interventions directed at
treatment in patients w/advanced, chronic illnesses; 2.
Methods of improving communication between adults living with
serious illness, their families and their health care providers;
3. Evaluating models and systems of care for patients living
with advanced illness and their families.
Due Dates: |
Nov 01 (OSR) Ι Nov 03 (Sponsor)
|
Amount & Project Period: |
$70,000 (Direct Costs) - 2 years
|
Eligibility: |
Must have full-time faculty position or equiv.
by award start Must be citizens/permanent residents of the United States
Must be <5 years out of post-doctoral fellowship
training
Must be able to commit minimum of 60% full-time effort on
patient-oriented research & relevant career development activities
|
Contact: |
Linda
Nolan (x6071) |
Link: |
NPCRC
|
|
NEW |
November 04 |
Postdocs |
Non-federal |
Career Development |
AACR-Bayer HealthCare
Hepatocellular Carcinoma Research Fellowship and
Prostate Cancer Research Fellowship
Research proposed for
Hepatocellular Carcinoma Research Fellowship funding may be basic, translational, clinical, or
epidemiological in nature and must have direct applicability and
relevance to gastric cancer, specifically non-Helicobactor
pylori associated gastric cancer
Research proposal for
Prostate
Cancer Research Fellowship must have direct
applicability and relevance to prostate cancer
|
NEW
|
November 6 (Noon, ET) |
Postdocs |
Non-federal |
Pancreatic |
2016 Pancreatic Cancer Action Network - NCI, Frederick
National Laboratory for Cancer Research
KRAS Fellowships
Supports KRAS research directly applicable and relevant to
pancreatic cancer with aims aligned with the Structural Biology
and Biochemistry priority area of the RAS Initiative.
Due Dates: |
November 04 (OSR) Ι November 06 (Sponsor) |
Amount & Project Period: |
$45,000 - 1 year (Plus $5,000
travel support) |
Eligibility: |
Hold a medical and/or doctoral degree
Hold a postdoctoral fellowship, clinical research fellowship or
equivalent
No citizenship requirements |
Contact: |
Linda
Nolan (x6071) |
Links: |
Fellowship Guidelines and Instructions
proposalCENTRAL
(Submission site) |
|
NCI is a
participating institute
NEW |
November 09 (LOI) |
All Ranks |
Federal |
Disorders of Sexual Development |
Multidisciplinary Approaches for Developmental Research with
Individuals with Disorders of Sexual Development
Research with individuals with disorders of sex development for
follow-up of cohorts with DSD to establish treatment outcomes,
cancer risks, and cancer-related health issues
Due Dates: |
Nov 09 (Letter of Intent)
Applications due: Dec 07 (OSR) Ι Dec 09 (Sponsor) |
Amount & Project Period: |
R01: No more than $499,000/yr (direct Costs) -
5 years
R21: $275,000 (Direct Costs - 2 years
R03: $100,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Links: |
R01:
RFA-HD-16-021
R21:
RFA-HD-16-023
R03:
RFA-HD-16-022 |
|
|
November 10 |
All Ranks |
Federal |
Exploratory/Developmental |
NCI Exploratory/Developmental Research Grant Program
(NCI Omnibus R21)
To encourage exploratory and developmental research projects at the early
and conceptual stages. Studies may involve considerable risk but
may lead to a breakthrough in a particular area, or to
development of novel techniques, agents, methodologies, models,
or applications that could have a major impact on a field of
cancer research
Due Dates: |
November 08 (OSR) November 10 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-340 |
|
|
November 16 |
Jr Faculty |
Non-federal |
Career Development |
Melanoma
Research
Alliance
Young
Investigator
Awards
To conduct
innovative,
translational
research
projects in
melanoma in the
area of
immunotherapy
Due Dates: |
Nov 14 (OSR) - Nov 16 (Sponsor)
|
Amount & Project Period: |
$75,000/yr - 3 years |
Eligibility: |
Must be within 4 years of first independent,
full time academic faculty appointment
Applicants who have secured an independent full-time faculty position
commencing by July 1, 2016 will be considered (a letter from an
institutional official or department chairperson confirming date of
faculty appointment is required at time of application |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals
|
|
|
November 16 |
Established Faculty |
Non-federal |
Industry Partnerships |
Melanoma
Research
Alliance (MRA)
Established
Investigator
Academic-Industry
Partnership
Awards
Designed to
enhance
translational
research by
extending
academic
capabilities to
clinical
investigations
and to
facilitate
interactions
between academic
and industrial
research sectors
Awards will be
co-funded by MRA
and an industry
partner whose
involvement is
essential to the
project
Due Dates: |
Nov 14 (OSR) - Nov 16 (Sponsor)
|
Amount & Project Period: |
$100,000/yr - 3 years (Industry funds and/or
in-kind support which must be at least 50% of the total support for the
project (e.g., reagents, clinical grade drugs, equipment, contract
services)) must match but may exceed MRA funds for the award period. |
Eligibility: |
Established Investigators
Industry scientists may serve as co-investigators or collaborators, but
may not be PIs |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals
|
|
|
November
17 |
All Faculty |
Federal |
Co-Clinical Trials |
Oncology Co-Clinical Imaging Research Resources to Encourage
Consensus on Quantitative Imaging Methods and Precision Medicine
The purpose of this FOA is to develop research that will
encourage a consensus on how Quantitative Imaging (QI) methods
are optimized to improve correlation of results for co-clinical
trials; defined as investigations in patients and in parallel
(or sequentially) in mouse or human-in-mouse models of cancer
that mirror the genetics and biology of the patients'
malignancies or pre-cancerous lesions.
The scientific goals are to: (a) perform the appropriate
optimization of the pre-clinical quantitative imaging methods,
(b) implement the optimized methods in the co-clinical trial,
and finally (c) populate a web-accessible research resource with
all the data, methods, workflow documentation, and results
collected from the co-clinical investigations.
Applicants are encouraged to organize multi-disciplinary teams
with experience in mouse models research, human investigations,
imaging platforms, QI methods, decision support software and
informatics to populate the research resource.
Due Dates: |
Nov 10 (OSR) -
Nov 17 (Sponsor) |
Amount & Project Period: |
$500,000/year for 5 years |
Eligibility: |
All Faculty |
Contact: |
Contact
Dr. Robert
Gillies |
FOA Link: |
PAR-15-266 |
|
NEW |
November 18 (Pre-application) |
All Ranks |
Federal |
Breast |
Breast Cancer Research Program
Breakthrough Award Levels 1 & 2
W81XWH-15-BCRP-BREAKTHROUGH2_FL12
Funding
Level 1: Innovative,
high-risk/high-reward research that is in the
earliest stages of idea development; Research
with potential to yield new avenues of
investigation; Proof of concept; No preliminary
data required
Funding
Level 2: Research that is
already supported by preliminary data and has
potential to make significant advancements
toward clinical translation; Demonstration of
efficacy in in vivo models, as applicable.
Due Dates: |
Nov 18 (Pre-app) Nov 30 (OSR) Dec
02 (Sponsor) |
Amount & Project Period: |
Funding Level 01: $375,000 - 3 years
Funding Level 02:
$750,000 - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
PA Link: |
Program Announcement
|
|
NCI is a participating Institute
|
November 30 |
See Below |
Federal |
SGM Health - Supplement |
Administrative Supplements for Research on
Sexual and Gender Minority(SGM) Populations
To
expand existing research to focus on Sexual and
Gender Minority (SGM) health
Intended to encourage investigation in this
underrepresented growing field of research.
Supplement will focus on areas of specific
research interest beyond HIV/AIDS, including,
but not limited to: studies on increased disease
risk; behavioral and social health; approaches
to personalized medicine; access to care;
reproductive and sexual development; and
resilience.
Due Dates: |
Nov 28 (OSR) - Nov 30 (Sponsor) |
Amount & Project Period: |
No more than $100,000 (Total Costs) - Project
and budget periods must be w/in currently approved project period for
existing parent award. All awards are for a one-year period |
Eligibility: |
Only active awards with at least 18 months
remaining at submission will be considered. Awards in
no-cost extension periods are not allowed to submit an application
Only one application per parent award may be submitted |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-329 |
|
|
November 30 |
All Ranks |
Federal |
Computational
Mathematics |
Division of Mathematical Sciences
Computational Mathematics
Supports mathematical research in areas of
science where computation plays a central and
essential role, emphasizing analysis,
development and implementation of numerical
methods and algorithms, and symbolic methods
Due Dates: |
Nov 28 (OSR) - Nov 30 (Sponsor)
|
Amount & Project Period: |
Budgets are not limited - generally 1- 3 years
|
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
PA Link: |
PD 16-1271 |
|
NEW |
December 01 |
See Below |
Non-federal |
Ovarian |
The Marsha Rivkin Center for Ovarian Cancer
Research
Rivkin Center Grants
|
|
Pilot
Study Program -
Investigator-initiated projects in all areas of
ovarian cancer research. Projects designed to
analyze data from already funded clinical trials
also considered.
|
|
Scientific
Scholar Award - To assist
promising laboratory and clinical scientists in
pursuing a career as an independent investigator
in ovarian cancer research
Amount & Project Period: |
$60,000 - 1 year |
Eligibility: |
Candidates should be at the post-doc/fellow,
instructor, research assistant, or assistant professor level with no
more than 3-4 years in any of these |
Links: |
RFA Ι
Scientific Scholar Program Guidelines |
|
|
December 01 |
All Ranks |
Non-federal |
Breast |
Earlier.Org
Pilot Projects
New methods to improve detection of early breast
cancer and development of new techniques in
areas of biological or immunologic methods of
early detection. Should represent a new
approach to the area of interest and cannot
enhance ongoing research unless it is clear that
a new line of inquiry is being explored.
Due Dates: |
Nov 25 (OSR) - Dec 01 (Sponsor) |
Amount & Project Period: |
$40,000 (Total) 1-3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Pilot Projects |
|
|
December 14 |
See Below |
Non-federal |
Interventional Radiology |
Society for Interventional Radiology (SIR)
|
|
Dr. Ernest J. Ring Academic Development
Grant
Provides support to junior Interventional Radiology faculty members early
in careers to allow time for the conduct of
research.
Amount & Project Period: |
$50,000/yr - 2 years |
Eligibility: |
Jr full-time faculty members, w/MD, DO, PhD, or
equivalent degree, not recognized as independent w/in 1st 5 years of
initial faculty appointment. |
|
|
Pilot Research Grant
Typically pilot or seed grant-type projects
testing a new idea.
Amount & Project Period: |
$25,000/yr - 1 year |
Eligibility: |
Must be active members of SIR
Fulltime interventional radiology
faculty and trainees Postdoctoral
candidates are invited to apply |
|
|
Allied Scientist Training Program
Priority areas include:
Tumor and Microenvironment Biology
Biomarker Development
Genetics
Imaging
Therapy
Amount & Project Period: |
$20,000/yr - 2 years |
Eligibility: |
Trainees enrolled in graduate level, degree
seeking programs (Masters, Doctor of Philosophy or equivalent) |
|
|
December 16 |
All Faculty |
Federal |
Collaborative/Translational
Research |
Pre-application: Opportunities for
Collaborative Research at the NIH Clinical
Center
To
accelerate and enhance translational science by
promoting partnerships between NIH intramural
investigators (e.g., those conducting research
w/in labs and clinics of the NIH) and
extramural investigators. NCI encourages
bench-to-bedside research to: increase
understanding of molecular and physiological
basis of health and disease; stimulate clinical
discoveries about mechanisms underlying disease
to develop improved prevention, diagnosis, and
treatment; enable translation of basic
discoveries into clinical practice; foster
training and mentoring of emerging scientists
and physicians; and communicate research
advances to public.
Due Dates: |
Dec 14 (OSR) - Dec 16 (Sponsor) |
Amount & Project Period: |
N/A - pre-application only |
Eligibility: |
All Faculty - Must include at least 1 intramural scientist as
Program Director/Principal Investigator or collaborator, and at least
some of the research must be conducted at the NIH Clinical Center. |
Contact: |
Linda Nolan
(x6071) |
FOA Link: |
PAR-15-286 |
|
NEW |
December 16 |
Jr faculty |
Non-federal |
Thoracic |
American Lung Association Junior
Investigator Awards - Mentor required
Biomedical Research Grant
Provides seed monies for researching the mechanisms of lung disease and
general lung biology
Due Dates: |
Dec 14 (OSR) Ι Dec 16 (Sponsor) |
Amount & Project Period: |
$40,000/yr |
Eligibility: |
Hold doctoral degree and a
faculty appointment
Fellows and PhD post-docs are eligible to apply
only if
their Department Chair can assure a promotion to faculty status by start
of award.
MD applicants must have completed two years of post-doctoral
research training by start of award |
Contact: |
Linda
Nolan (x6071) |
Links: |
Instructions
proposalCENTRAL
(Submission site) |
|
NEW |
Clinical Patient Care Research Grant
Provides seed monies to conduct trials for the
improvement of patient care and treatment for
lung disease.
|
NEW |
Dalsemer Research Grant
Provides seed monies to research mechanisms and biology of interstitial
lung disease.
|
NEW |
American Lung Association - Training Awards
Senior Research Training Fellowships
Research on mechanisms of lung disease and
general lung biology
Due Dates: |
Dec 14 (OSR) Ι Dec 16 (Sponsor) |
Amount & Project Period: |
$32,500/yr (Up to $16,000 may be used student
stipend but may not be used for tuition) |
Eligibility: |
PhD applicants
must be in 1st or 2nd year of training at time of application.
MD or DO applicants must also
have completed clinical training, have some research experience, and be
in 3rd or 4th year of training at time of application
Persons with medical degrees,
whose credentials show that they are on a career track which will not
include practice of medicine, must be in 1st or 2nd year of full-time
postdoctoral research. Fellows are expected to devote their fulltime,
and in no case less than 75% of their time, to research training |
Link: |
proposalCENTRAL (Submission site) |
|